局部晚期胰腺癌的临床试验
总计2980个结果
-
Centre Oscar LambretCanceropôle Nord Ouest招聘中
-
Radiation Therapy Oncology GroupGlaxoSmithKline; Novartis完全的
-
University of RochesterBristol-Myers Squibb; Syntrix Biosystems, Inc.招聘中
-
Translational Drug DevelopmentTranslational Genomics Research Institute主动,不招人
-
Pancreatic Cancer Research TeamMerck Sharp & Dohme LLC; University of Washington; Halozyme Therapeutics未知
-
Roswell Park Cancer InstituteBayer完全的
-
Genentech, Inc.BioNTech SE招聘中
-
Amal TherapeuticsBoehringer Ingelheim招聘中
-
University Hospital, GrenobleNETRIS Pharma招聘中
-
University Health Network, Toronto招聘中
-
Washington University School of MedicineBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of Health (NIH); The...主动,不招人
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Apexigen, Inc.完全的
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Chang Gung Memorial Hospital; National Cheng-Kung University...完全的
-
Clovis Oncology, Inc.完全的转移性胰腺癌美国, 比利时, 加拿大, 澳大利亚, 英国, 德国, 意大利, 阿根廷, 俄罗斯联邦, 法国, 巴西, 瑞典, 挪威, 荷兰, 乌克兰
-
Samsung Medical Center完全的
-
Replimune Inc.Roche Pharma AG尚未招聘
-
Silenseed Ltd完全的
-
Mayo ClinicNational Cancer Institute (NCI)招聘中
-
Anne NoonanNational Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)完全的不可切除的胰腺癌 | 转移性胰腺癌 | III 期胰腺癌 AJCC v6 和 v7 | IV 期胰腺癌 AJCC v6 和 v7美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Washington University School of MedicineNational Cancer Institute (NCI)招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Swim Across America Laboratory完全的
-
Centre Hospitalier Universitaire Dijon完全的
-
AstraZeneca终止Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC芬兰